Specialty products refiner Calumet (NASDAQ: CLMT) reported Q3 2026 results beating Wall Street’s revenue expectations, with sales up 56.1% year on year to $1.68 billion. Its non-GAAP profit of $2.79 per share was 55.1% above analysts’ consensus estimates.

Is now the time to buy CLMT? Find out in our full research report (it’s free for active Edge members).

StockStory’s take

Calumet delivered above-consensus top- and bottom-line results in the third quarter, but the market reacted negatively, reflecting investor concerns about margin compression and sustainability of recent outperformance. Management attributed quarterly gains to both its specialty products and renewables segments operating at full capacity amid tight supply conditions. CEO Todd Borgmann emphasized that plant reliability investments and an integrated specialty system helped Calumet capitalize on global supply chain disruptions, while also noting that the commercial team prioritized long-term customer relationships over chasing spot market margins. Borgmann cautioned that the current operating environment is elevated and not indicative of a new normal, stating, “What we will not point to this quarter is a new long-term norm.”

Looking forward, Calumet’s guidance is shaped by persistent global supply shortages in specialty products and an accelerated ramp in renewable fuel production, particularly sustainable aviation fuel (SAF). Management expects the specialty market to remain tight for several quarters due to slow infrastructure repairs and ongoing disruptions, while the Montana Renewables segment is set to benefit from its MaxSAF expansion and new asset tie-ins. CFO David Lunin highlighted that further deleveraging and improved operational reliability are expected to drive higher cash flow conversion, with management planning to use excess cash to pay down high-cost debt and pursue select growth investments. At the same time, executives noted that margins may gradually normalize as global supply chains recover.

Key insights from management’s remarks

Management credited the quarter’s outperformance to strong execution across specialty and renewables, but highlighted that supply disruptions and operational improvements were key differentiators.

• Specialty segment resilience: The specialty products and solutions business benefited from global supply constraints, with more than 10% of paraffinic base oil capacity offline due to geopolitical events and plant damage. Management said this allowed Calumet to maintain high price premiums and achieve its eighth consecutive quarter of specialty sales above 20,000 barrels a day.

• Renewables ramp drives growth: Montana Renewables delivered its first full quarter of ramped operation, supported by the MaxSAF expansion and new asset tie-ins. The segment’s top-quartile cost structure and flexibility in feedstocks and products were cited as competitive advantages, particularly as U.S. renewable diesel and SAF demand remains robust.

• Operational reliability investments: Completion of a major turnaround at the Shreveport facility improved production capacity and reliability, positioning Calumet to increase specialty segment volumes in the coming quarters. Management believes ongoing reliability projects will further extend performance gains.

• Debt reduction accelerates: Calumet retired approximately $265 million of debt in the past four months, saving $26 million in annual interest. Management indicated that deleveraging remains the top priority, using strong cash flows from both segments to reduce high-cost borrowings.

• Performance Brands margin lag: The Performance Brands segment faced margin pressure from input cost increases outpacing retail price adjustments, due to a typical 60-90 day price lag. Management expects margins to normalize as pricing actions take hold, but acknowledged that volatility in input costs remains a risk.

Drivers of future performance

Management’s outlook is shaped by continued supply tightness, an expanded renewables platform, and ongoing debt reduction, but acknowledges potential margin normalization as supply chains recover.

• Supply constraints support pricing: Management expects the global specialty products market to remain tight into next year, as plant repairs and inventory rebuilds are slow. This supply shortage is enabling Calumet to sustain higher price premiums, though executives noted that these conditions are unlikely to last indefinitely.

• Renewables expansion key to growth: The MaxSAF expansion and new asset tie-ins at Montana Renewables are expected to increase sustainable aviation fuel production rates and throughput capacity. Management believes these enhancements will drive additional margin and volume growth, with the ability to flex between renewable diesel, SAF, and renewable NGLs (natural gas liquids) depending on market conditions.

• Focus on deleveraging and selective investment: Excess cash is slated for further debt repayment and targeted growth investments, with management emphasizing that capital allocation decisions will be evaluated against shareholder value creation. However, executives acknowledged that as global supply chains recover, margins could gradually return toward historical mid-cycle levels.

Catalysts in upcoming quarters

In the upcoming quarters, StockStory analysts will be watching (1) progress on the Montana Renewables MaxSAF expansion and its ability to ramp SAF production, (2) the pace of global supply chain normalization in specialty products and whether pricing power is sustained, and (3) further balance sheet deleveraging through debt repayments. Execution on operational reliability improvements and margin trends in Performance Brands will also be key markers to track.

Calumet currently trades at $40.67, down from $43.35 just before the earnings. Is the company at an inflection point that warrants a buy or sell? Find out in our full research report (it’s free).

Now could be the perfect time to invest in these stocks

WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.

But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+214% between June 2020 and June 2025). Find your next big winner with StockStory today.